Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MindBio Therapeutics Corp. C.MBIO

Healthcare Biotechnology
MindBio Therapeutics Corp is a pioneering clinical stage biotechnology company that specializes in developing psychedelic microdosing treatments for mental health conditions. MindBio has obtained government and regulatory approvals for at-home LSD microdosing in clinical trials, making it the only organization in the world to do so.


CSE:MBIO - Post by User

MindBio Therapeutics Corp.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(469)
•••
Post by Smokey1958on May 14, 2024 7:02am
37 Views
Post# 36038171

Interim Financials MD&A

Interim Financials MD&Ahttps://www.sedarplus.ca/csa-party/viewInstance/resource.html?node=W2713&drmKey=f15a810d73e220dc&drr=ssdce1bb7a0428697a25c094be37a60aedabf47d5bbe20ba73ed283640cea37bba1020e5a8d0497bd1ff5e8c80aa62b8fcux&id=0c11f8b7998bcd96ea2edbdcae428e20b7b846c5298b3638
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities